BLINATUMOMAB
Clinical trials for BLINATUMOMAB explained in plain language.
Never miss a new study
Get alerted when new BLINATUMOMAB trials appear
Sign up with your email to follow new studies for BLINATUMOMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug hope for kids with tough-to-treat lupus
Disease control Recruiting nowThis early study tests if blinatumomab can help children with severe lupus that hasn't responded to other treatments. Six participants will receive two short courses of the drug and be monitored for a year. The goal is to see if symptoms improve and to track any side effects.
Matched conditions: BLINATUMOMAB
Phase: PHASE1 • Sponsor: Mao Jianhua • Aim: Disease control
Last updated May 26, 2026 10:50 UTC
-
New drug combo offers hope for leukemia patients who Can't tolerate chemo
Disease control Recruiting nowThis study tests a two-step immunotherapy approach for people with B-cell acute lymphoblastic leukemia (B-ALL) who are older, too frail for standard chemo, or whose cancer has returned. Participants will receive two targeted drugs in sequence: blinatumomab and inotuzumab ozogamic…
Matched conditions: BLINATUMOMAB
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC